- Oct 24, 2014
Researchers identify new target for treating childhood cancers
Scientists at the University of Liverpool have uncovered a new target for drugs that could battle a lethal childhood cancer known as...
- Oct 6, 2014
FDA grants orphan drug designation for neuroblastoma vaccine
The U.S. Food and Drug Administration (FDA) granted orphan drug designation for a neuroblastoma vaccine from MabVax Therapeutics,...
- Jul 31, 2014
New DNA technology may improve the treatment of aggressive childhood cancer
Neuroblastoma, a form of cancer, is the most common childhood tumour outside of the brain, and the one that has been the most difficult...
- May 9, 2014
Experimental antibody shows early promise for treatment of childhood tumor
Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a...
- May 5, 2014
Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Chil
Alliance of Australian and U.S. researchers and children's cancer advocates focused on developing drugs as potential treatments for...
- Apr 1, 2014
Differentiation therapy holds promise as a targeted therapy for pediatric neuroblastoma
The important role of microRNAs in regulating neuroblastoma development has been unveiled by new research. This finding points to new...
- Mar 11, 2014
New Cancer Treatment Offered in Minnesota Gives Families Hope
There are about 700 new cases of neuroblastoma in the U.S. every year, according to the American Cancer Institute. It's a type of...
- Mar 4, 2014
Improved screening means new targets for pediatric neuroblastoma therapies
Neuroblastoma is one of the most common and lethal types of childhood cancers. In a paper published online today in OncoTarget, a...